{"disease":{"id":"human-papillomavirus-18","name":"human papillomavirus 18"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00090220","title":"A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3819,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04000503","title":"Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2019,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT00804466","title":"Human Papillomavirus Epidemiology in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":1466,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03439085","title":"DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT03603808","title":"VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":false},{"nct_id":"NCT00798265","title":"A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}